Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3757781015 | Bosentan hydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3757782010 | Bosentan hydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bosentan hydrochloride | Has disposition | Endothelin receptor antagonist | true | Inferred relationship | Existential restriction modifier | ||
| Bosentan hydrochloride | Is modification of | Bosentan | true | Inferred relationship | Existential restriction modifier | ||
| Bosentan hydrochloride | Is a | Substance with endothelin receptor antagonist mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely bosentan (as bosentan hydrochloride) 62.5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | False | Bosentan hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
| Product containing precisely bosentan (as bosentan hydrochloride) 125 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | False | Bosentan hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR